California Academy of Family Physicians (CAFP)
MAY 14, 2025
However, for individuals who do not qualify for federal Medicaid funding—such as most undocumented immigrants—the federal government does not provide matching funds, even when those individuals meet income eligibility requirements. The asset limit for a household would be $2,000 for an individual and $3,000 per couple.
FDA Law Blog
OCTOBER 13, 2024
Designed to incentivize the development of drugs for pediatric rare diseases where such development may not otherwise have occurred, vouchers may be granted for drugs for serious or life-threatening rare diseases where the serious or life-threatening manifestations primarily affect individuals aged from birth to 18 years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
FEBRUARY 13, 2025
FDA provides definitions for the three datasets. The update procedures should include plans for required labeling changes and training provided to end users. Post-market surveillance plans and procedures (PMS) are a requirement under ISO 13485 which will be adopted into FDAs Quality Management System Regulation in 2026.
FDA Law Blog
SEPTEMBER 20, 2021
Below we provide an overview of some of the goals letter’s most notable contents such as new initiatives as well as some large-scale enhancements to programs that have already been in the works. Pandemic influences aside, the FY 2023-2027 goals letter contained many notable new initiatives, announcements, and commitments.
Alabama Academy of Family Physicians
FEBRUARY 19, 2025
What Happened: Passed out of the House of Representatives HB 46 – Rural Physicians Tax Credit What’s in the Bill: HB 46 terminates the existing Rural Physician Tax Credit program in Alabama, which provided tax credits to physicians practicing in rural areas, effective December 31, 2025.
ABIM
JUNE 24, 2025
Advanced Practice Providers in the Hematology-Oncology Workforce* Guinevere Z. Lillie, MSN, FNP-C, AOCNP , a public member of the Hematology Board and advanced practice provider (APP) at the Inova Schar Cancer Institute, led a discussion about the integration of APPs in hematology and differences among clinical practices.
FDA Law Blog
JULY 7, 2024
To be sure, Table 2 provides a handy visual of the categories of LDTs, the timeline for phaseout, and the scope of enforcement discretion for each test category. However, the guidance provides no new information on how FDA expects laboratories to implement these new requirements.
Expert insights. Personalized for you.
130 
Let's personalize your content